Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Modulation of ABCC9 Pathways by Nicorandil for the Treatment of Hippocampal Sclerosis of Aging: SMArT-HS

NCT04120766 is registered in ClinicalTrials.gov with Gregory Jicha, MD, PhD as lead sponsor.

NCT NCT04120766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04120766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Modulation of ABCC9 Pathways by Nicorandil for the Treatment of Hippocampal Sclerosis of Aging: SMArT-HS
Lead sponsor
Gregory Jicha, MD, PhD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 1, 2021
Completion date
November 30, 2026
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, mild cognitive impairment